Buy One Get One free -Llimited Time Offer X
Switus A is a prescription medicine that is available as a Liquid. Other than this, Switus A has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Switus A is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Switus A also has some side effects, the most common being Constipation, Heartburn, Nausea or vomiting. Some other side effects of Switus A have been listed ahead. These side effects of Switus A are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Switus A is Moderate for pregnant women and Moderate for women who are breastfeeding. In addition, Switus A's effects on the liver, heart and kidney are discussed below in the Switus A related warnings section.
Switus A can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Switus A in conditions like Gastrointestinal Bleeding, Glaucoma, Asthma. Some other conditions that can be affected by Switus A are listed in the contraindications section below.
Additionally, Switus A may also adversely react with other medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Switus A is considered not safe while driving, and is not addictive.
Switus A is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Switus A is used -
Severe
Mild
Common
Is the use of Switus A safe for pregnant women?
Switus A may have some side effects during pregnancy. Pregnant women should discontinue the use of Switus A, and talk to their doctor, if they notice any discomfort.
Is the use of Switus A safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Switus A. Immediately discontinue Switus A if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Switus A on the Kidneys?
Using Switus A does not have any harmful effects on kidneys.
What is the effect of Switus A on the Liver?
Switus A is completely safe for the liver.
What is the effect of Switus A on the Heart?
Switus A is completely safe for the heart.
Switus A should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Switus A unless your doctor advises you to do so -
Is this Switus A habit forming or addictive?
Switus A is not addictive in nature.
Interaction between Food and Switus A
Taking Switus A with food is safe.
Interaction between Alcohol and Switus A
No research has been done on this till date. Therefore, it is not known what the effect of taking Switus A with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 219
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,165
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Guaifenesin
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 629-631